Literature DB >> 17365733

Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature.

Timothy J Wilt1, Dennis Niewoehner, Robert L Kane, Roderick MacDonald, Anne M Joseph.   

Abstract

Obtaining spirometric testing and providing those results to individuals who smoke has been advocated as a motivational tool to improve smoking cessation. However, its effectiveness is not known. We conducted a systematic review to determine if this approach improves rates of smoking cessation. Data sources included MEDLINE (1966 to October 2005), the Cochrane Library, and experts in the field. Eligible randomized controlled trials (RCTs) enrolled at least 25 smokers per arm, evaluated spirometry with associated counseling or in combination with other treatments, followed subjects at least 6 months, and provided smoking abstinence rates. Results from nonrandomized studies also were summarized. The primary outcome was patient-reported long-term (at least 6 months) sustained abstinence with biological validation. Additional outcomes included self-reported abstinence and point-prevalence abstinence. Seven RCTs (N = 6,052 subjects) met eligibility criteria. Follow-up duration ranged from 9 to 36 months. In six trials, the intervention group received concomitant treatments previously demonstrated to increase cessation independently. The range of abstinence was 3%-14% for control subjects and 7%-39% among intervention groups, statistically significantly in favor of intervention in four studies. The only RCT that assessed the independent contribution of spirometry in combination with counseling demonstrated a nonsignificant 1% improvement in patient-reported point-prevalence abstinence at 12 months in the group that received spirometry plus counseling versus counseling alone (6.5% versus 5.5%). Findings from observational studies were mixed, and the lack of controls makes interpretation problematic. Available evidence is insufficient to determine whether obtaining spirometric values and providing that information to patients improves smoking cessation compared with other smoking cessation methods. Spirometric values are of limited benefit as a predictor of smoking cessation or as a tool to "customize" smoking cessation strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17365733     DOI: 10.1080/14622200601078509

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  18 in total

1.  Dawning of a new lung age?

Authors:  Brendan Cooper
Journal:  Prim Care Respir J       Date:  2012-03

2.  Impact of spirometry feedback and brief motivational counseling on long-term smoking outcomes: a comparison of smokers with and without lung impairment.

Authors:  Jennifer B McClure; Evette J Ludman; Lou Grothaus; Chester Pabiniak; Julie Richards
Journal:  Patient Educ Couns       Date:  2010-08

Review 3.  Diagnosis and early detection of COPD using spirometry.

Authors:  David P Johns; Julia A E Walters; E Haydn Walters
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

4.  Biomedical risk assessment as an aid for smoking cessation.

Authors:  Carole Clair; Yolanda Mueller; Jonathan Livingstone-Banks; Bernard Burnand; Jean-Yves Camain; Jacques Cornuz; Myriam Rège-Walther; Kevin Selby; Raphaël Bize
Journal:  Cochrane Database Syst Rev       Date:  2019-03-26

5.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

6.  Immediate and short-term impact of a brief motivational smoking intervention using a biomedical risk assessment: the Get PHIT trial.

Authors:  Jennifer B McClure; Evette Ludman; Lou Grothaus; Chester Pabiniak; Julie Richards; Amy Mohelnitzky
Journal:  Nicotine Tob Res       Date:  2009-03-18       Impact factor: 4.244

7.  Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease?

Authors:  R Perez-Padilla; W M Vollmer; J C Vázquez-García; P L Enright; A M B Menezes; A S Buist
Journal:  Int J Tuberc Lung Dis       Date:  2009-03       Impact factor: 2.373

Review 8.  What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?

Authors:  Nitin Y Bhatt; Karen L Wood
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

9.  COPD: an underdiagnosed disease at hospital environment.

Authors:  Levent Kart; Muhammed Emin Akkoyunlu; Mehmet Bayram; Fatih Yakar; Hatice Kutbay Özçelik; Fatmanur Karaköse; Murat Sezer
Journal:  Wien Klin Wochenschr       Date:  2013-11-19       Impact factor: 1.704

10.  Impact of a brief motivational smoking cessation intervention the Get PHIT randomized controlled trial.

Authors:  Jennifer B McClure; Evette J Ludman; Louis Grothaus; Chester Pabiniak; Julie Richards
Journal:  Am J Prev Med       Date:  2009-06-12       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.